Rio Boothello
Affiliations: | 2009-2014 | Virginia Commonwealth University, Richmond, VA, United States |
Google:
"Rio Boothello"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Umesh R. Desai | grad student | 2009-2014 | VCU | |
| (PhD: Studies on Rationally Designed, Allosteric Coagulation Inhibitors) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Morla S, Ravikumar O, O'Hara C, et al. (2023) Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting Anticancer Activity. Journal of Medicinal Chemistry |
| Boothello RS, Sankaranarayanan NV, Sistla JC, et al. (2022) Glycan Modulation of Insulin-like Growth Factor-1 Receptor. Angewandte Chemie (International Ed. in English) |
| Boothello RS, Desai U. (2022) Thermodynamic Affinity and Nature of Forces Defining Glycosaminoglycan-Protein Systems Using Fluorescence Spectroscopy. Methods in Molecular Biology (Clifton, N.J.). 2303: 259-278 |
| Pingali P, Wu YJ, Boothello R, et al. (2021) High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity. Neoplasia (New York, N.Y.). 23: 348-359 |
| Kalita M, Chua JS, Boothello RS, et al. (2020) Visualizing antithrombin-binding 3--sulfated heparan sulfate motifs on cell surfaces. Chemical Communications (Cambridge, England) |
| Boothello RS, Sankaranarayanan NV, Afosah DK, et al. (2020) Studies on fragment-based design of allosteric inhibitors of human factor XIa. Bioorganic & Medicinal Chemistry. 28: 115762 |
| Boothello RS, Sankaranarayanan NV, Afosah DK, et al. (2020) Studies on fragment-based design of allosteric inhibitors of human factor XIa. Bioorganic & Medicinal Chemistry. 28: 115762 |
| Omar AM, El-Araby ME, Abdelghany TM, et al. (2020) Introducing of potent cytotoxic novel 2-(aroylamino)cinnamamide derivatives against colon cancer mediated by dual apoptotic signal activation and oxidative stress. Bioorganic Chemistry. 101: 103953 |
| Sharon C, Boothello R, Vera A, et al. (2019) Abstract 4667: A synergistic combination strategy for optimal inhibition of colon cancer stem cells: Simultaneous inhibition of Insulin-like growth factor-1 receptor-AKT-mammalian target of rapamycin axis and the mevalonate-isoprenoid biosynthetic pathway Cancer Research |
| Boothello RS, Patel NJ, Sharon C, et al. (2018) A Unique Non-Saccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. Molecular Cancer Therapeutics |